Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis B Vaccinated Children Not At Increased Risk Of MS
The majority of children vaccinated against hepatitis B are not at an increased risk of developing multiple sclerosis (MS). The study based in France involved 349 children with MS and 2,941 children without the disease. The children were all under the

Drug Watch: Agents in late-stage development for the treatment of hepatitis B and C virus infections (October 2008) (PDF)
Extract not available.

Biolex Therapeutics Completes $60 Million Series D Financing To Accelerate Development Of Locteron In Hepatitis C
Extract not available.

UPDATES AND COMMENTARY RSS Feed

Medical Device Boasts Encouraging Data for Hepatitis C Treatment
A medical device designed to clear viruses and immunosuppressive proteins from the blood reduced Hepatitis C viral load for several people on dialysis. Further case studies will determine if the Aethlon Hemopurifier® can induce a rapid virological response against Hepatitis...

Hepatitis C Study Increases Interest in SCV-07
Trial results show SciClone's SCV-07 effectively reduces Hepatitis C viral load in previous non-responders with genotype 1. Based on these encouraging results, a follow-up study to evaluate SCV-07's potential to replace or improve the current Hepatitis C standard treatment will...

New Hope for HCV
Funded by Pfizer, Tacere's licensed RNAi technology could change the way Hepatitis C is treated. A mechanism that inhibits genes from transferring information and creating new genetic material, RNAi-based drugs may be able to silence the genes that cause disease....

Hepatitis D


By Howard J. Worman, M. D.

The Hepatitis D virus (also called delta virus) is a small circular RNA virus. The Hepatitis D virus is replication defective and therefore cannot propagate in the absence of another virus. In humans, Hepatitis D virus infection only occurs in the presence of Hepatitis B infection.

Hepatitis D virus infection is transmitted by blood and blood products.

The risk factors for infection are similar to those for Hepatitis B virus infection. The Hepatitis D virus most often infects intravenous drug users.

A patient can acquire Hepatitis D virus infection at the same time as he/she is infected with the Hepatitis B virus. This is called co-infection. A patient with Hepatitis B can be infected with Hepatitis D virus at any time after acute Hepatitis B virus infection. This is called super-infection.

Hepatitis D virus super- infection should be suspected in a patient with chronic Hepatitis B whose condition suddenly worsens. There is usually an obvious history of continued exposure to blood or blood products (eg. an active intravenous drug user). A particularly aggressive acute Hepatitis B infection could suggest Hepatitis D co- infection. Co-infection or super-infection with Hepatitis D virus in a patient with Hepatitis B is diagnosed by the presence of antibodies against the Hepatitis D virus. IgM antibodies indicate acute infection.

Interferon-alpha is used to treat patients with chronic Hepatitis B and Hepatitis D infection. Some studies have suggested that a dose higher than that usually used for Hepatitis B infection may be beneficial.

Copyright, 1995, Columbia University Division of Gastroenterology
Hepatitis D/Howard J. Worman, M.D./hjw14@columbia.edu

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 07 Oct 2008